TSHB
Basic information
Region (hg38): 1:115029826-115034302
Links
Phenotypes
GenCC
Source:
- isolated thyroid-stimulating hormone deficiency (Definitive), mode of inheritance: AR
- isolated thyroid-stimulating hormone deficiency (Strong), mode of inheritance: AR
- isolated thyroid-stimulating hormone deficiency (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Hypothyroidism, congenital, nongoitrous, 4 | AR | Endocrine | The untreated condition can result in severe neurological damage, and recognition can allow early medical treatment with thyroid hormone replacement can prevent such sequelae | Endocrine | 2792087; 1971148; 8636437; 9589689; 11297590; 11549695; 12364478; 11788671; 15292359; 16804796 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (5 variants)
- Isolated thyroid-stimulating hormone deficiency (2 variants)
- Pituitary hypothyroidism (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TSHB gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 24 | 24 | ||||
missense | 11 | 14 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 3 | 4 | |||
non coding | 10 | |||||
Total | 4 | 1 | 12 | 31 | 5 |
Highest pathogenic variant AF is 0.000158
Variants in TSHB
This is a list of pathogenic ClinVar variants found in the TSHB region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-115029849-A-G | Isolated thyroid-stimulating hormone deficiency | Likely benign (Jan 13, 2018) | ||
1-115033094-A-G | Benign (Nov 12, 2018) | |||
1-115033374-C-T | Likely benign (Sep 26, 2023) | |||
1-115033389-GC-G | Pathogenic (Sep 26, 2023) | |||
1-115033402-A-G | not specified • Congenital hypothyroidism • Isolated thyroid-stimulating hormone deficiency | Benign (Feb 01, 2024) | ||
1-115033403-C-T | Inborn genetic diseases | Uncertain significance (Sep 01, 2021) | ||
1-115033416-G-A | Likely benign (Jan 27, 2024) | |||
1-115033443-T-C | Likely benign (Sep 08, 2023) | |||
1-115033455-C-T | Likely benign (Jan 17, 2024) | |||
1-115033456-G-T | Isolated thyroid-stimulating hormone deficiency | Pathogenic (May 01, 1990) | ||
1-115033466-AGT-A | Isolated thyroid-stimulating hormone deficiency | Pathogenic (-) | ||
1-115033474-T-C | Inborn genetic diseases | Uncertain significance (Jan 17, 2024) | ||
1-115033494-C-T | Likely benign (Jun 28, 2023) | |||
1-115033498-A-T | Inborn genetic diseases | Uncertain significance (May 31, 2022) | ||
1-115033503-T-G | not specified | Uncertain significance (May 22, 2024) | ||
1-115033507-G-A | Isolated thyroid-stimulating hormone deficiency | Pathogenic (May 23, 2024) | ||
1-115033521-A-G | Likely benign (Jan 17, 2024) | |||
1-115033522-C-A | Likely benign (Mar 27, 2023) | |||
1-115033529-G-A | Isolated thyroid-stimulating hormone deficiency | Pathogenic (Feb 20, 2024) | ||
1-115033540-C-T | Benign (Jan 28, 2024) | |||
1-115033541-A-G | Likely benign (Apr 16, 2023) | |||
1-115033542-C-T | Likely benign (Jan 25, 2024) | |||
1-115033861-C-G | Benign (Jun 19, 2021) | |||
1-115033947-T-C | TSHB-related disorder | Uncertain significance (Oct 18, 2023) | ||
1-115033953-C-T | Likely benign (Jul 26, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TSHB | protein_coding | protein_coding | ENST00000256592 | 2 | 4527 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00836 | 0.583 | 125709 | 0 | 8 | 125717 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.304 | 66 | 73.3 | 0.900 | 0.00000357 | 906 |
Missense in Polyphen | 22 | 25.194 | 0.87321 | 319 | ||
Synonymous | -0.519 | 29 | 25.7 | 1.13 | 0.00000127 | 263 |
Loss of Function | 0.215 | 3 | 3.43 | 0.875 | 1.45e-7 | 58 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000616 | 0.0000616 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Indispensable for the control of thyroid structure and metabolism.;
- Pathway
- Regulation of lipolysis in adipocytes - Homo sapiens (human);Thyroid hormone synthesis - Homo sapiens (human);Autoimmune thyroid disease - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Human Thyroid Stimulating Hormone (TSH) signaling pathway;Signaling by GPCR;Signal Transduction;Peptide hormone metabolism;Metabolism of proteins;GPCR signaling-G alpha q;Metabolism of amino acids and derivatives;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;Metabolism;G alpha (s) signalling events;Hormone ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;GPCR signaling-G alpha i;TSH;Thyroxine biosynthesis;Amine-derived hormones;Glycoprotein hormones;GPCR downstream signalling;Peptide hormone biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.649
Intolerance Scores
- loftool
- 0.460
- rvis_EVS
- 0.3
- rvis_percentile_EVS
- 72.01
Haploinsufficiency Scores
- pHI
- 0.629
- hipred
- N
- hipred_score
- 0.398
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tshb
- Phenotype
- growth/size/body region phenotype; reproductive system phenotype;
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;cell-cell signaling;anatomical structure morphogenesis;hormone-mediated signaling pathway;regulation of signaling receptor activity;peptide hormone processing;response to vitamin A;response to estrogen;response to calcium ion
- Cellular component
- extracellular region;extracellular space;cytoplasm
- Molecular function
- hormone activity